BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 24613492)

  • 1. Outcomes and treatment patterns as a function of time in stage IS testicular seminoma: a population-based analysis.
    Ahmed KA; Wilder RB
    Cancer Epidemiol; 2014 Apr; 38(2):124-8. PubMed ID: 24613492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overall survival analysis of adjuvant radiation versus observation in stage I testicular seminoma: a surveillance, epidemiology, and end results (SEER) analysis.
    Jones G; Arthurs B; Kaya H; Macdonald K; Qin R; Fairbanks RK; Lamoreaux WT; Jawed I; Tward JD; Martincic D; Shivnani AT; Lee CM
    Am J Clin Oncol; 2013 Oct; 36(5):500-4. PubMed ID: 22781383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stage IIA and IIB testicular seminoma treated postorchiectomy with radiation therapy versus other approaches: a population-based analysis of 241 patients.
    Ahmed KA; Wilder RB
    Int Braz J Urol; 2015; 41(1):78-85. PubMed ID: 25928512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excellent long-term disease control with modern radiotherapy techniques for stage I testicular seminoma--the Mayo Clinic experience.
    Hallemeier CL; Choo R; Davis BJ; Leibovich BC; Costello BA; Pisansky TM
    Urol Oncol; 2014 Jan; 32(1):24.e1-6. PubMed ID: 23490907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcomes of radiotherapy for stage II testicular seminoma--the Mayo Clinic experience.
    Hallemeier CL; Pisansky TM; Davis BJ; Choo R
    Urol Oncol; 2013 Nov; 31(8):1832-8. PubMed ID: 22537538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis of primary testicular seminoma: a report on 57 new cases.
    Fujikawa K; Matsui Y; Oka H; Fukuzawa S; Sasaki M; Takeuchi H
    Cancer Res; 2000 Apr; 60(8):2152-4. PubMed ID: 10786678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human chorionic gonadotropin-positive seminoma patients: A registry compiled by the global germ cell tumor collaborative group (G3).
    Seidel C; Daugaard G; Nestler T; Tryakin A; Fedyanin M; Fankhauser C; Hermanns T; Aparicio J; Heinzelbecker J; Paffenholz P; Heidenreich A; De Giorgi U; Cathomas R; Lorch A; Fingerhut A; Gayer F; Bremmer F; Giannatempo P; Necchi A; Aurilio G; Casadei C; Tran B; Dieckmann KP; Brito M; Ruf C; Oing C; Bokemeyer C
    Eur J Cancer; 2020 Jun; 132():127-135. PubMed ID: 32361383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Observation versus adjuvant radiation or chemotherapy in the management of stage I seminoma: clinical outcomes and prognostic factors for relapse in a large US cohort.
    Soper MS; Hastings JR; Cosmatos HA; Slezak JM; Wang R; Lodin K
    Am J Clin Oncol; 2014 Aug; 37(4):356-9. PubMed ID: 23275274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant radiation therapy in stage I seminoma: 20 years of oncologic results.
    De Felice F; Musio D; Gravina GL; Marampon F; Tombolini V
    Oncotarget; 2016 Nov; 7(48):80077-80082. PubMed ID: 27556300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stage I testicular seminoma: results of adjuvant irradiation and surveillance.
    Warde P; Gospodarowicz MK; Panzarella T; Catton CN; Sturgeon JF; Moore M; Goodman P; Jewett MA
    J Clin Oncol; 1995 Sep; 13(9):2255-62. PubMed ID: 7666083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stage II Testicular Seminoma: Patterns of Care and Survival by Treatment Strategy.
    Glaser SM; Vargo JA; Balasubramani GK; Beriwal S
    Clin Oncol (R Coll Radiol); 2016 Aug; 28(8):513-21. PubMed ID: 27146264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management and outcomes of clinical stage IIA/B seminoma: Results from the National Cancer Data Base 1998-2012.
    Paly JJ; Lin CC; Gray PJ; Hallemeier CL; Beard C; Sineshaw H; Jemal A; Efstathiou JA
    Pract Radiat Oncol; 2016; 6(6):e249-e258. PubMed ID: 27345128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
    Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
    Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of BHCG and local tumor invasion in stage I seminoma of the testis.
    Schwartz BF; Auman R; Peretsman SJ; Moul JW; Deshon GE; Hernandez J; Rozanski RA; Thrasher JB
    J Surg Oncol; 1996 Feb; 61(2):131-3. PubMed ID: 8606544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of care and survival outcomes for adolescent and young adult patients with testicular seminoma in the United States: A National Cancer Database analysis.
    Stokes W; Amini A; Maroni PD; Kessler ER; Stokes C; Cost CR; Greffe BS; Garrington TP; Liu AK; Cost NG
    J Pediatr Urol; 2017 Aug; 13(4):386.e1-386.e7. PubMed ID: 28153774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Urologic treatment of testicular germ cell cancer].
    Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
    Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment burden in stage I seminoma: a comparison of surveillance and adjuvant radiation therapy.
    Leung E; Warde P; Jewett M; Panzarella T; O'Malley M; Sweet J; Moore M; Sturgeon J; Gospodarowicz M; Chung P
    BJU Int; 2013 Dec; 112(8):1088-95. PubMed ID: 23937685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term survival in patients with germ cell testicular cancer: a population-based competing-risks regression analysis.
    Gandaglia G; Becker A; Trinh QD; Abdollah F; Schiffmann J; Roghmann F; Tian Z; Montorsi F; Briganti A; Karakiewicz PI; Sun M
    Eur J Surg Oncol; 2014 Jan; 40(1):103-12. PubMed ID: 24099755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncological outcomes in patients with stage I testicular seminoma and nonseminoma: pathological risk factors for relapse and feasibility of surveillance after orchiectomy.
    Kobayashi K; Saito T; Kitamura Y; Nobushita T; Kawasaki T; Hara N; Takahashi K
    Diagn Pathol; 2013 Apr; 8():57. PubMed ID: 23566361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Management of clinical stage I testicular germ cell tumours].
    Loriot Y; Fizazi K
    Bull Cancer; 2007 May; 94(5):439-48. PubMed ID: 17535781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.